7 terminated. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Terminated 7 |
Follow Parathyroid Diseases: new trials by email Literature Review of Parathyroid Diseases trials Research Report on Parathyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation Indocyanine green, SPY Portable Handheld Imaging - Parathyroid Dysfunction, Adenoma | Phase 4 | Terminated | University of Alabama at Birmingham | 417 | 2024-04-11 | 2026-05-06 |
| Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Calcitriol, Paricalcitol - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Terminated | Winthrop University Hospital | 16 | 2012-11-01 | 2023-11-07 |
| Denosumab in Primary Hyperparathyroidism Denosumab, Placebo - Primary Hyperparathyroidism | Phase 4 | Terminated | Columbia University | 8 | 2012-01-01 | 2022-11-02 |
| Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects Calcitriol, Paricalcitol - Secondary Hyperparathyroidism, Dialysis | Phase 4 | Terminated | Abbott | 13 | 2009-01-01 | 2012-01-20 |
| Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients doxercalciferol - Hyperparathyroidism, Secondary | Phase 4 | Terminated | Emory University | 12 | 2008-04-01 | 2015-01-26 |
| Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis cinacalcet - Secondary Hyperparathyroidism | Phase 4 | Terminated | Papageorgiou General Hospital | 15 | 2006-07-01 | 2014-10-29 |
| Active Vitamin D Effect on Left Ventricular Hypertrophy Alfacalcidiol - Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 4 | Terminated | Per Ivarsen | 24 | 2002-01-01 | 2015-12-08 |
Hyperparathyroidism, Secondary (5) · Adenoma (1) · Bone Diseases, Metabolic (1) · Hypercalcemia (1) · Hyperparathyroidism, Primary (1) · Hyperphosphatemia (1) · Hypertrophy, Left Ventricular (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Endocrine System Diseases (7) · Hyperparathyroidism (6) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Bone Diseases (1) · Calcium Metabolism Disorders (1) · Cardiomegaly (1) · Cardiovascular Diseases (1)
Calcitriol (2) · paricalcitol (2) · 1 alpha-hydroxyergocalciferol (1) · Cinacalcet (1) · Denosumab (1) · Indocyanine Green (1)
Abbott (1) · Columbia University (1) · Emory University (1) · Papageorgiou General Hospital (1) · Per Ivarsen (1) · University of Alabama at Birmingham (1) · Winthrop University Hospital (1)
United States (4) · Brazil (1) · Denmark (1) · Greece (1)
Efstathios Mitsopoulos, MD (1) · Herbert Chen, MD (1) · John P Bilezikian, MD (1) · Lino Rodrigues, MD (1) · Per Ivarsen, MD, PhD (1) · Shayan Shirazian, MD (1)
R01DK032333 (1)